About Isologic

This author has not yet filled in any details.
So far Isologic has created 31 blog entries.

Isologic Launches Illuccix® PSMA PET Imaging Agent to Detect Prostate Cancer

2023-03-17T08:33:50-04:00March 16th, 2023|

Montreal, March 16th, 2023 – Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix®, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada. 24,000 men are diagnosed with prostate cancer each year in Canada, making it the number one cancer among men. "Health Canada has [...]

Telix and Isologic sign License and Distribution Agreement for Illuccix® for Canada

2022-11-27T14:04:02-05:00June 22nd, 2022|

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a license and distribution agreement with Isologic Innovative Pharmaceuticals Ltd (Isologic) for the commercialisation of Telix’s investigational prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga-68 gozetotide injection), also known as 68Ga-PSMA-11 injection, for the Canadian market. Please follow the link [...]

Product Update: I-131 Dx capsule supply

2022-11-27T14:04:59-05:00January 11th, 2019|

PRODUCT UPDATE - January 10th, 2019 MONTREAL, January 10th, 2019 Dear Customer, We would like to inform you of our I-131 Dx capsule supply. We will have 100 μCi diagnostic capsules available on January 21st. These capsules will have a calibration date of January 23rd. We also have [...]

Product Update

2022-11-27T14:05:06-05:00December 24th, 2018|

PRODUCT UPDATE - DECEMBER 20th, 2018 MONTREAL, DEC. 20th, 2018 Dear Customer, We would like to inform you that due to an unforeseeable I-131 Dx capsule production issue we will not be able to produce and ship I-131 Dx capsule for an undetermined period of time. We have [...]

First diagnostic radiotracer for early diagnosis of Alzheimer’s disease approved in Canada

2022-11-27T14:41:51-05:00March 1st, 2018|

PIRAMAL IMAGING SA AND ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ANNOUNCE COMMERCIAL APPROVAL OF NEURACEQ™ BY HEALTH CANADA MONTREAL, Feb. 28, 2017 /CNW Telbec Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce that Health Canada has issued a Notice of Compliance (NOC) to ISOLOGIC Innovative Radiopharmaceuticals for [...]

IRE-ELiT S.A. & Isologic Sign Exclusive Agreement

2018-04-05T16:11:22-04:00January 31st, 2018|

IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic signed an exclusive agreement for the distribution of Galli Eo™ 68Ge/ 68Ga generator in Canada FLEURUS, Belgium ; Montreal, Canada ; the 31st January. IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic Innovative Radiopharmaceuticals, the Canadian leader in radiopharmacy servicess [...]

ISOLOGIC Acquires Lantheus Canadian Imaging Centres

2022-11-27T14:58:05-05:00January 14th, 2016|

ISOLOGIC Acquires Lantheus Canadian Imaging Centres ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ACQUIRES LANTHEUS MEDICAL IMAGING CANADIAN RADIOPHARMACEUTICAL CENTRES ISOLOGIC is pleased to announce the completion of an asset purchase agreement for the acquisition of the Canadian radiopharmacy and Gludef manufacturing and distribution business operations of Lantheus [...]

Toronto Area Better Equipped

2023-10-13T09:32:57-04:00July 7th, 2015|

GREATER TORONTO AREA BETTER EQUIPPED TO PRODUCE RADIOPHARMACEUTICAL COMPONENTS USED IN CANCER, CARDIAC AND ALZHEIMER’S DETECTION A new cyclotron and radiopharmaceutical manufacturing facility, opened by ISOLOGIC Innovative Radiopharmaceuticals Ltd. (ISOLOGIC) at Toronto’s Sunnybrook Health Sciences Centre, is expanding access to positron emitting radiopharmaceuticals (PERs), an essential [...]

Go to Top